When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

In addition to delivering quality releases and consistent functionality across these tools and experiences that enable you to efficiently manage and develop with Microsoft SQL Server, we are aiming ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Google added a very useful feature to the Google Search Console Insights report named query groups. It does what it is named, it groups similar queries together as one, so you can see how your site is ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Google’s query fan-out technique issues multiple background searches based on initial question. This system is active across AI Mode, Deep Search, and some AI Overview results. The approach relies on ...

Altman shared the unsourced statistic in a new blog post. Altman shared the unsourced statistic in a new blog post. is a senior reporter covering technology, gaming, and more. He joined The Verge in ...